Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TS03 Inc Trust Units TSTIF

Healthcare Medical Instruments & Supplies


GREY:TSTIF - Post by User

TS03 Inc Trust Units > Olympus AGAIN!
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(29)
•••
Comment by elgin1on Jul 24, 2016 1:39pm
116 Views
Post# 25079737

RE:RE:RE:RE:Olympus AGAIN!

RE:RE:RE:RE:Olympus AGAIN! Maybe someone can ask Rumble directly at the cc in a weeks time? Ask Rumble if they have the modified scopes and if they are testing them. That news alone (or proven steilization of Q180 scopes would push the stock price to $4.   Too much at stake for Olympus and FDA not to have the VP4 sterilize the Olympus Q180 scopes.  Great find Lematou.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities